$BNTX BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD

on July 19, 2021 News and Tags: , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
BNTX
Source:
GlobeNewswire News Releases
Read more

$GILD Four-Year Biktarvy® Data Presented at IAS 2021 Demonstrate High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults

on July 17, 2021 News and Tags: , , , with 0 comments
Time:
6:01 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021

on July 15, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD NRx Pharmaceuticals Announces Partnership with the Israel Institute for Biological Research to Complete Development and Commercialization of BriLife™ COVID Vaccine

on July 12, 2021 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
11:18 AM
Symbol:
GILD
Source:
PR Newswire
Read more

$GILD Gilead to Present New Data at IAS 2021 Demonstrating the Company’s Commitment to Advancing Innovation in HIV Research

on July 12, 2021 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma

on June 28, 2021 News and Tags: , , , with 0 comments
Time:
8:30 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead’s Veklury® (Remdesivir) Associated With a Reduction in Mortality Rate in Hospitalized Patients With COVID-19 Across Three Analyses of Large Retrospective Real-World Data Sets

on June 21, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead to Present More Than 70 Abstracts From Diverse Liver Disease Programs At The International Liver Congress™ 2021

on June 21, 2021 News and Tags: , , , with 0 comments
Time:
4:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies

on June 17, 2021 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors

on June 14, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
4:45 PM
Symbol:
GILD
Source:
PR Newswire
Read more

$GILD Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis

on June 12, 2021 News and Tags: , , , with 0 comments
Time:
10:00 AM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

on June 10, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Reducing Our Footprint: It’s Time to Get More Ambitious

on June 9, 2021 News and Tags: , , , with 0 comments
Time:
4:50 AM
Symbol:
GILD
Source:
3BL Media: Corporate Social Responsibility, Energy and Health News
Read more

$GILD Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021

on May 19, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences to Present at Upcoming Investor Conferences

on May 14, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences Announces Second Quarter 2021 Dividend

on April 29, 2021 News and Tags: , , , with 0 comments
Time:
4:02 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India

on April 26, 2021 News and Tags: , , , with 0 comments
Time:
6:34 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer

on April 14, 2021 News and Tags: , , , with 0 comments
Time:
9:25 AM
Symbol:
GILD
Source:
PR Newswire
Read more

$GILD U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer

on April 13, 2021 News and Tags: , , , with 0 comments
Time:
5:42 PM
Symbol:
GILD
Source:
Business Wire News Releases
Read more

$GILD Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metasta

on April 8, 2021 News and Tags: , , , with 0 comments
Time:
8:10 PM
Symbol:
GILD
Source:
PR Newswire
Read more